NAGIOS: RODERIC FUNCIONANDO

Study of the role of BCL-XL in healthy aging and frailty prevention

Repositori DSpace/Manakin

IMPORTANT: Aquest repositori està en una versió antiga des del 3/12/2023. La nova instal.lació está en https://roderic.uv.es/

Study of the role of BCL-XL in healthy aging and frailty prevention

dc.contributor.advisor	Borrás Blasco, Consuelo
dc.contributor.advisor	Viña Ribes, José
dc.contributor.advisor	Mas Bargues, Cristina
dc.contributor.author	Román Domínguez, Aurora
dc.contributor.other	Departament de Fisiologia	es_ES
dc.date.accessioned	2023-02-20T09:54:33Z
dc.date.available	2023-02-21T05:45:06Z
dc.date.issued	2022	es_ES
dc.date.submitted	03-03-2023	es_ES
dc.identifier.uri	https://hdl.handle.net/10550/85489
dc.description.abstract	Aging is defined as an intrinsic, progressive, deleterious and inevitable multifactorial phenomenon that occurs as a result of the gradual accumulation of damage at cellular and molecular levels. Due to the recent discovery of BCL-XL being overexpressed in peripheral blood mononuclear cells from centenarians, a new approach has emerged to investigate the BCL-XL function in healthy aging. The major goal of this thesis is to study the role of BCL-XL in frailty and healthy aging in transgenic mice overexpressing a human form of BCL-XL in T cells. For this, we used the heterozygous transgenic mice from Cg-Tg(LCKprBCL2L1)12Sjk/J strain, which express the human BCL-XL cDNA sequence in all thymocyte subsets. We measured physical performance parameters such as spontaneous activity, body weight, grip strength, motor coordination, physical endurance, and frailty. We also measured metabolic parameters such as respiratory metabolism, intake, body composition and glucose tolerance. We also measured T cell purity, cellular senescence, apoptosis, autophagy, cell death and mitochondrial function. Our results showed that transgenic mice exhibit better physical performance reduced frailty at advanced ages. Mice total body mass and body fat percentage were positively correlated with age in wild type mice but not in transgenic mice although no differences of intake were observed between strains. Additionally, a reduction of glucose intolerance in 15-23-month-old transgenic mice was observed. In T cells, increased autophagic response to starvation was observed in old transgenic mice-derived T cells compared to wild type-derived T cells. Additionally, apoptosis was increased in transgenic mice-derived T cells at 17-20 months of age under physiological conditions (freshly isolated cells). On the contrary, apoptosis was reduced in transgenic mice-derived T cells at 2-5 and 8-11 months of age under more hostile conditions (cultured cells), both in absence and in presence of the apoptotic inducer dexamethasone. When studying mitochondrial function of T cells, we also observed a significantly reduction of oxygen consumption rate and proton leak under basal conditions in 2-5 and 8-11-month-old transgenic mice-derived T cells compared to wild type mice-derived T cells. In conclusion, BCL-XL overexpression in T cells attenuates physical performance and prevents frailty during aging, helps to maintain a youthful body composition and enhanced glucose tolerance in transgenic mice. In addition, T cells overexpressing BCL-XL exhibit an enhanced cellular function by being more resistant to apoptosis under stressful conditions, showing an improved autophagic response to starvation and having a lower oxygen consumption and proton leak.	es_ES
dc.format.extent	318 p.	es_ES
dc.language.iso	es	es_ES
dc.subject	BCL-XL	es_ES
dc.subject	aging	es_ES
dc.subject	frailty	es_ES
dc.subject	cellular function	es_ES
dc.subject	molecular biology	es_ES
dc.title	Study of the role of BCL-XL in healthy aging and frailty prevention	es_ES
dc.type	doctoral thesis	es_ES
dc.subject.unesco	UNESCO::CIENCIAS MÉDICAS	es_ES
dc.embargo.terms	0 days	es_ES